Research Paper Volume 15, Issue 11 pp 4889—4905
Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma
Figure 6. The plots of LASSO, survival analyses, and AUC in the KRAS-mutated group of training set and validating set. (A, B) The plots of LASSO analysis. (C) The KM curve in the KRAS-mutated group. (D) The time-dependent ROC curves in the KRAS-mutated group. (E) The clinicopathologic ROC curves in the KRAS-mutated group. (F) The heatmap of the expression values of the prognostic immune-related genes. (G) The KM curve in the KRAS-mutated group of validating set. (H) The time-dependent ROC curves in the KRAS-mutated group of validating set.